Serum Institute of India (SII), whose Covishield vaccine has already received restricted emergency use approval by the Drugs Controller General of India (DCGI), has now sought permission to start clinical trials of 'Covovax', a Covid-19 vaccine developed by Novavax.
Adar Poonawalla, CEO of SII, in a tweet said: "Our partnership for a Covid-19 vaccine with Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch Covovax by June 2021."
A day after US President Donald Trump on Monday announced the landmark India-US trade deal and that he would reduce reciprocal tariffs from 25 per cent to 18 per cent, a massive political war has erupted in Delhi.
In an exclusive interview with India Today's Geeta Mohan and Marya Shakil, American journalist Tucker Carlson spoke on a wide range of issues, including the US-India trade deal and the role of social media.
This Get Real India report focusses on a horrific crime in Maharashtra's Nanded district, where a seven-year-old girl was allegedly murdered by her father to contest panchayat elections.
This edition of News Today focusses on the newly announced trade pact between India and the United States following a phone call between Prime Minister Narendra Modi and President Donald Trump.
